当前位置:首页 - 行情中心 - 中钢洛耐(688119) - 财务分析 - 利润表

中钢洛耐

(688119)

  

流通市值:45.79亿  总市值:45.79亿
流通股本:11.25亿   总股本:11.25亿

利润表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、营业总收入541,376,196.772,187,812,794.331,639,928,188.481,128,999,596
营业收入541,376,196.772,187,812,794.331,639,928,188.481,128,999,596
二、营业总成本520,276,516.92,209,761,071.941,639,985,766.821,124,070,639.67
营业成本451,841,1831,853,642,524.791,376,095,879.79951,345,507.18
税金及附加6,074,996.9424,275,749.1216,303,762.2910,603,706.26
销售费用12,028,041.6758,819,285.9142,096,543.4329,229,203.1
管理费用25,738,041.25138,101,740.05105,751,883.272,596,751.06
研发费用20,995,045.46126,462,931.0694,725,606.8558,594,957.83
财务费用3,599,208.588,458,841.015,012,091.261,700,514.24
其中:利息费用5,166,592.5625,859,567.3219,158,683.9813,177,993.75
其中:利息收入1,292,968.4612,427,284.2210,677,736.369,636,593.7
加:公允价值变动收益-831,331.15-698,079.49-18,658.591,519,079.61
加:投资收益3,336,305.2411,233,485.2910,852,305.275,851,016.89
资产处置收益--16,016.29-
资产减值损失(新)-1,520,893.37-19,217,240.84-7,648,372.48-6,974,038.27
信用减值损失(新)-2,796,334.89-59,291,936.58-29,404,405.26-23,525,914.98
其他收益3,550,211.9742,707,603.6829,999,278.7720,392,810.3
营业利润平衡项目0000
四、营业利润22,837,637.67-47,214,445.553,738,585.662,191,909.88
加:营业外收入2,319,557.29609,588.55529,997.9168,541.8
减:营业外支出539,555.82,036,460.76295,358.32144,332.08
利润总额平衡项目0000
五、利润总额24,617,639.16-48,641,317.763,973,225.242,216,119.6
减:所得税费用2,946,342.734,031,494.235,310,359.094,761,437.73
六、净利润21,671,296.43-52,672,811.99-1,337,133.85-2,545,318.13
持续经营净利润21,671,296.43-52,672,811.99-1,337,133.85-2,545,318.13
归属于母公司股东的净利润19,597,245.36-59,096,852.39-5,970,936.07-5,560,997.23
少数股东损益2,074,051.076,424,040.44,633,802.223,015,679.1
(一)基本每股收益0.02-0.05-0.010
(二)稀释每股收益0.02-0.05-0.010
八、其他综合收益--16,658,741.58-26.02-
归属于母公司股东的其他综合收益--16,658,741.58-26.02-
九、综合收益总额21,671,296.43-69,331,553.57-1,337,159.87-2,545,318.13
归属于母公司股东的综合收益总额19,597,245.36-75,755,593.97-5,970,962.09-5,560,997.23
归属于少数股东的综合收益总额2,074,051.076,424,040.44,633,802.223,015,679.1
公告日期2025-04-292025-04-292024-10-302024-08-29
审计意见(境内)标准无保留意见
TOP↑